These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7079004)

  • 1. Erythrocyte nucleotides in children--increased blood lead and cytidine triphosphate.
    Angle CR; McIntire MS; Swanson MS; Stohs SJ
    Pediatr Res; 1982 Apr; 16(4 Pt 1):331-4. PubMed ID: 7079004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lead chelation therapy with EDTA in children on erythrocyte pyrimidine 5'-nucleotidase and with cytidine triphosphate levels.
    Swanson MS; Angle CR; Stohs SJ
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):497-500. PubMed ID: 6293983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of erythrocyte nucleotides and their pattern in lead workers.
    Sakai T; Araki T; Ushio K
    Arch Environ Health; 1990; 45(5):273-7. PubMed ID: 2256711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal erythrocyte pyrimidine nucleotides in uremic subjects.
    Angle CR; Swanson MS; Stohs SJ; Markin RS
    Nephron; 1985; 39(3):169-74. PubMed ID: 2983249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of lead exposure in workers at a lead-acid battery factory in Korea: with focus on activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).
    Kim Y; Harada K; Ohmori S; Lee BK; Miura H; Ueda A
    Occup Environ Med; 1995 Jul; 52(7):484-8. PubMed ID: 7670624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte arginase, pyrimidine 5'-nucleotidase (P5N), and deoxypyrimidine 5'-nucleotidase (dP5N) as indices of lead exposure.
    Cook LR; Angle CR; Stohs SJ
    Br J Ind Med; 1986 Jun; 43(6):387-90. PubMed ID: 3013277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on erythrocyte pyrimidine 5'-nucleotidase (P5N) test and its evaluation in workers occupationally exposed to lead.
    Ichiba M; Tomokuni K
    Int Arch Occup Environ Health; 1990; 62(4):305-10. PubMed ID: 2379961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between inhibition of erythrocyte pyrimidine 5'-nucleotidase activity and biological response for porphyrin metabolism in workers occupationally exposed to lead.
    Tomokuni K; Ichiba M; Hirai Y; Hasegawa T; Sugimoto K
    Int Arch Occup Environ Health; 1988; 60(6):431-6. PubMed ID: 2842263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte nucleotides in lead workers.
    Ichiba M; Tomokuni K; Mori K
    Int Arch Occup Environ Health; 1992; 63(6):419-21. PubMed ID: 1544691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
    Lachant NA; Zerez CR; Tanaka KR
    Biochim Biophys Acta; 1989 Jan; 994(1):81-8. PubMed ID: 2535789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte nucleotides from control and lead-treated rabbits.
    Swanson MS; Angle CR; Stohs SJ; Rovang KS
    Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):353-61. PubMed ID: 6245437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reviews on biochemical markers of lead exposure with special emphasis on heme and nucleotide metabolisms].
    Sakai T
    Sangyo Eiseigaku Zasshi; 1995 Mar; 37(2):99-112. PubMed ID: 7749999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low level lead and inhibition of erythrocyte pyrimidine nucleotidase.
    Angle CR; McIntire MS
    Environ Res; 1978 Oct; 17(2):296-302. PubMed ID: 233817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of blood lead by HPLC assay of erythrocyte pyrimidine 5'-nucleotidase.
    Cook LR; Angle CR; Kubitschek CE; Stohs SJ
    J Anal Toxicol; 1987; 11(1):39-42. PubMed ID: 3029506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte protoporphyrin versus blood lead: relationship with iron status among children exposed to gross environmental pollution.
    Carvalho FM; Silvany-Neto AM; Barbosa AC; Cotrim CR; Tavares TM
    Environ Res; 1995 Oct; 71(1):11-5. PubMed ID: 8757233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of lead exposure in workers at secondary lead smelters in South Korea: with focus on activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).
    Kim Y; Lee H; Lee CR; Park DU; Yang JS; Park IJ; Lee KY; Lee M; Kim TK; Sohn NS; Cho YS; Lee N; Chung HK
    Sci Total Environ; 2002 Mar; 286(1-3):181-9. PubMed ID: 11886093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lead-induced accumulation of erythrocyte pyrimidine nucleotides in the rabbit.
    Angle CR; Stohs SJ; McIntire MS; Swanson MS; Rovang KS
    Toxicol Appl Pharmacol; 1980 Jun; 54(1):161-7. PubMed ID: 7394785
    [No Abstract]   [Full Text] [Related]  

  • 18. Distribution of erythrocyte nucleotides in pyrimidine 5'-nucleotidase deficiency.
    Torrance JD; Whittaker D
    Br J Haematol; 1979 Nov; 43(3):423-34. PubMed ID: 497119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte pyrimidine 5'-nucleotidase inhibition by acute lead exposure in neonatal rats.
    Konantakieti C; Beuthin FC; Louis-Ferdinand RT
    J Biochem Toxicol; 1986 Sep; 1(3):51-9. PubMed ID: 2856073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dose-effect relationships between blood lead and free erythrocyte protoporphyrin or zinc protoporphyrin].
    Sun GL
    Zhonghua Yu Fang Yi Xue Za Zhi; 1989 Sep; 23(5):279-82. PubMed ID: 2625062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.